Molnupiravir has shown to be a promising option for treating feline infectious peritonitis as a first- and second-line ...

Wedgewood, the nation’s largest provider of compounded veterinary medications, announces the addition of molnupiravir to its ...

Today, Wedgewood announces the addition of molnupiravir to its formulary. Originally developed for human viral infections, including COVID-19, molnupiravir has emerged as a promising option for ...

A new COVID variant, XEC, has arrived just before fall. The new variant has sprouted from the Omicron variant that developed ...

New research has found that molnupiravir offers modest longer term benefits to vaccinated adults. This is the latest outcome of the NIHR funded and delivered PANORAMIC trial, led by the University of ...

Researchers indicate that the vaccine and booster shots should protect against the new variant. Here is what we know about ...

“These latest findings from the award-winning PANORAMIC study will help policy makers make decisions about the use of ...

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful ...

Vista Outdoor Inc. ("Vista Outdoor", the "Company") today issued the following statement from the Company's Chairman of the Board, Michael Callahan: We are committed to continuing to explore all ...